Trials / Unknown
UnknownNCT01798251
XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of Stomach
A Randomized Single Center Phase II Study Comparing XELOX With Capecitabine Maintenance or XELOX Treatment in Elderly Metastatic Adenocarcinoma of Stomach
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Harbin Medical University · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
To confirm the efficacy and safety of XELOX with capecitabine maintenance in treatment of elderly advanced gastric cancer (AGC) by comparing it with that of XELOX regimen.
Detailed description
To investigate whether XELOX with capecitabine maintenance treatment as 1st line treatment in the elderly advanced gastric cancer is as effective and safe as XELOX regimen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxaliplatin | Oxaliplatin 100mg/m2 d1 Intravenous infusion every 3 weeks |
| DRUG | Capecitabine | capecitabine 850mg/m2 bid, d1-14, every 3 weeks |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2014-12-01
- Completion
- 2015-12-01
- First posted
- 2013-02-25
- Last updated
- 2013-05-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01798251. Inclusion in this directory is not an endorsement.